(PRRT) of Gastro-Entero-Pancreatic NeuroEndocrine Tumors

More documents

Recommendations

Info

Targeted Drugs Imaging, therapy, new target finding Systematic search Target finding Mol. Imaging Radionuclide Therapy Genetic profiling “Fishing” Diagnosis Localization Therapy selection Evaluation/Monitoring
Proof of Concept in Prostate Cancer Bombesin [ 111 In-DTPA] DTPA]-ProPro 1 ,Tyr 4 -BN SPECT scan 24 h p.i. 111 In A 2 SPECT bone scan 1 3 B 2 SPECT [ 111 In-DTPA] DTPA]-ProPro 1 ,Tyr 4 -BN 111 In 1 3
Page 1 and 2: Molecular Medicine Same Molecule/Ta
Page 3: Targeted Radionuclide Therapy with
Page 7 and 8: Molecular Medicine of GEPNET Introd
Page 9 and 10: Cytoreductive therapies for inopera
Page 11 and 12: Structure of a Radiopeptide Recepto
Page 13 and 14: Molecular Imaging at ErasmusMC
Page 15 and 16: Molecular Medicine at ErasmusMC
Page 17 and 18: [ 177 Lu-DOTA 0 ,Tyr 3 ]Octreotate
Page 27 and 28: PRRT with LuTate in GEPNET shows an
Page 31 and 32: Future Developments for PRRT in GEP
Page 33: Radiolabelled [DOTA 0 ,Tyr 3 ]Octre

(PRRT) of Gastro-Entero-Pancreatic NeuroEndocrine Tumors

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?